4-氯-1-甲基硫烷基-2-硝基苯 | 1889-57-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-氯-1-甲基硫烷基-2-硝基苯
• 中文别名: 4-氯-2-硝基硫代苯甲醚
• 英文名称: methyl 4-chloro-2-nitrophenyl sulfide
• 英文别名: (4-chloro-2-nitrophenyl)(methyl)sulfane；5-Chlor-2-methylmercapto-nitrobenzol；Methyl-(2-nitro-4-chlor-phenyl)-sulfid；Methyl-(4-chlor-2-nitrophenyl)-thioether；(4-chloro-2-nitro-phenyl)-methyl sulfide；(4-Chlor-2-nitro-phenyl)-methyl-sulfid；4-chloro-6-nitrophenyl methyl sulfide；4-Chlor-2-nitro-thioanisol；4-Chloro-1-(methylsulfanyl)-2-nitrobenzene；4-chloro-1-methylsulfanyl-2-nitrobenzene
• CAS: 1889-57-2
• 化学式: C₇H₆ClNO₂S
• mdl: MFCD00156134
• 分子量: 203.649
• InChiKey: FVYWHGBTHWHFQV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  71.1
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2930909090

反应信息

• 作为反应物：
  描述：

  4-氯-1-甲基硫烷基-2-硝基苯 在 铁粉 、 溶剂黄146 作用下， 以 乙酸乙酯 为溶剂， 反应 3.0h， 生成 5-氯-2-（甲硫基）苯胺
  参考文献：
  名称：

  2-异氰基芳基硫醚的离子反应性：获得 2-卤素和 2-氨基苯并噻吩/硒唑

  摘要：

  已成功开发了硫杂/硒官能化芳基异氰化物的离子级联插入/环化反应，用于高效、实用地合成 2-卤代苯并噻唑/苯并硒唑衍生物。这种合成方案在形成苯并噻吩/硒唑的五元环时加入了一个卤素原子，与现有的方案不同，其中发生了预先形成的苯并噻吩/硒唑前体的卤化。此外，还可以通过 2-异氰基芳基硫醚、碘和胺的一锅级联反应轻松获得 2-氨基苯并噻唑。

  DOI：

  10.1021/acs.joc.1c02747
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 生成 4-氯-1-甲基硫烷基-2-硝基苯
  参考文献：
  名称：

  Frank,O., Dissert.

  摘要：

  DOI：

文献信息

• Palladium-Catalyzed Decarboxylative Methylthiolation of Aromatic Carboxylic Acids by Using DMSO as the Sulfurizing Reagent
  作者：Zhengjiang Fu、Zhaojie Li、Qiheng Xiong、Hu Cai

  DOI：10.1002/ejoc.201403147

  日期：2014.12

  By using simple and readily available DMSO as a convenient and environmentally friendly source of sulfur, a practical approach for the Pd-catalyzed decarboxylative methylthiolation of 2-nitrobenzoic acids was developed. A range of substituents on the aryl group of the ortho-nitrobenzoic acid were compatible with this process.

  通过使用简单易得的 DMSO 作为一种方便且环保的硫源，开发了一种用于 Pd 催化的 2-硝基苯甲酸脱羧甲硫基化的实用方法。邻硝基苯甲酸的芳基上的一系列取代基与该过程相容。
• Copper-catalyzed decarboxylative methylthiolation of aromatic carboxylate salts with DMSO
  作者：Liang Hu、Dadian Wang、Xiang Chen、Lin Yu、Yongqi Yu、Ze Tan、Gangguo Zhu

  DOI：10.1039/c7ob01315a

  日期：——

  A novel copper-catalyzed decarboxylative methylthiolation of arenecarboxylate salts has been realized using DMSO as the methylthiolation source. Various potassium aryl carboxylates underwent decarboxylative methylthiolation under air to furnish the corresponding aryl methyl thioethers in moderate to excellent yields. The reaction tolerated a wide variety of functional groups. Notably, the synthesis

  使用DMSO作为甲基硫醇化来源，已经实现了芳族羧酸盐的新型铜催化的脱羧甲基硫醇化。各种芳基羧酸钾在空气中进行了脱羧甲基硫醇化反应，以中等至优异的产率提供了相应的芳基甲基硫醚。该反应可耐受多种官能团。值得注意的是，在相似的反应条件下，也可以直接由二乙基亚砜直接成功地完成乙基硫醚的合成。
• Silver halide color photographic material
  申请人：FUJI PHOTO FILM CO., LTD.

  公开号：EP0394943A2

  公开（公告）日：1990-10-31

  A silver halide color photographic material comprising a support having thereon at least one silver halide emulsion layer, wherein the silver halide color photographic material contains an image forming compound represented by the following general formula (I): (Dye-X)q-Y      (I) wherein Dye represents a cyan dye group represented by the general formula (II) described below or a precursor thereof; X represents a chemical bond or a linking group; Y represents a group having a property of releasing Dye in correspondence or counter-corres­pondence to development of a light-sensitive silver salt having a latent image distributed imagewise and making a difference in diffusibility between the dye thus-­released and the compound represented by (Dye-X)q-Y; Dye and X are connected with each other by C or E in the general formula (II); and q represents an integer of 1 or 2, and when q is 2, the two groups (Dye-X) may be the same or different: wherein A represents a halogen atom, -OR¹ or -SR¹ (wherein R¹ represents an alkyl group, an aryl group or a heterocyclic group); B represents an electron withdrawing group having a Hammett's σp value of not less than 0.3; C represents a chemical bond, a hydrogen atom, an alkyl group, a cycloalkyl group, an aryl group, a halogen atom, -OR⁴, -CONR⁴R⁵, -SO₂NR⁴R⁵, -N(R³)-COR₄ or -N(R³) -SO₂R₄ (wherein R³, R⁴ and R⁵ each represents a hydrogen atom or a group selected from those defined for R¹, or R⁴ and R⁵ may combine with each other to form a 5-­membered or 6-membered ring); E represents a chemical bond, a hydrogen atom, an alkyl group, a halogen atom, -OR⁴, -CONR⁴R⁵, -SO₂NR⁴R⁵, -N(R⁵)-COR⁴ or -N(R⁵)-SO₂R⁴ (wherein R⁴ and R⁵ have the same meaning as defined above); and G represents a hydroxy group or a salt thereof, or a group selected from those represented by the formula (T), (U) or (V): wherein R²¹ and R²², which may be the same or different, each represents an alkyl group, a cycloalkyl group, an alkenyl group, an aralkyl group, an aryl group, a heterocyclic group, an alkylthio group, an arylthio group, an alkoxy group, an aryloxy group or an amino group, or R²¹ and R²² may combine with each other to form a 5-membered or 6-membered ring.

  一种卤化银彩色感光材料，包括一个支撑体，支撑体上至少有一层卤化银乳剂层，其中卤化银彩色感光材料含有由下式通式(I)表示的图像形成化合物： (Dye-X)q-Y (I) 其中，染料代表由下述通式（II）表示的青色染料基团或其前体；X 代表化学键或连接基团；Y 代表一种基团，该基团具有在显影时相应或反相应地释放染料的特性，该银盐具有按图像方向分布的潜像，并使由此释放的染料与（Dye-X）q-Y 所代表的化合物之间的扩散性不同；染料和 X 在通式(II)中通过 C 或 E 相互连接；q 代表 1 或 2 的整数，当 q 为 2 时，两个基团 (Dye-X) 可以相同或不同： 其中 A 代表卤素原子、-OR¹ 或 -SR¹（其中 R¹ 代表烷基、芳基或杂环基）； B 代表具有不小于 0.3;C 代表化学键、氢原子、烷基、环烷基、芳基、卤素原子、-OR⁴、-CONR⁴R⁵、-SO₂NR⁴R⁵、-N(R³)-COR₄或 -N(R³)-SO₂R₄（其中 R³、和 R⁵ 各代表一个氢原子或一个选自 R¹ 所定义的基团，或 R⁴ 和 R⁵ 可相互结合形成一个 5 元环或 6 元环）；E 代表化学键、氢原子、烷基、卤素原子、-OR⁴、-CONR⁴R⁵、-SO₂NR⁴R⁵、-N(R⁵)-COR⁴ 或 -N(R⁵)-SO₂R⁴（其中 R⁴ 和 R⁵ 的含义与上述定义相同）；G 代表羟基或其盐，或选自式 (T)、(U) 或 (V) 所代表的基团： 其中 R²¹ 和 R²²（可以相同或不同）各自代表烷基、环烷基、烯基、芳烷基、芳基、杂环基、烷硫基、芳硫基、烷氧基、芳氧基或氨基，或 R²¹ 和 R²² 可相互结合形成 5 元环或 6 元环。
• DI(ARYLAMINO)ARYL COMPOUND
  申请人：Astellas Pharma Inc.

  公开号：EP2172461A1

  公开（公告）日：2010-04-07

  The present invention provides a compound which is useful as an inhibitor against the kinase activity of EML4-ALK fusion proteins and mutant EGFR proteins. As a result of extensive and intensive studies on compounds having an inhibitory effect against the kinase activity of EML4-ALK fusion proteins and mutant EGFR proteins, the inventors of the present invention have found that the di(arylamino)aryl compound of the present invention has inhibitory activity against the kinase activity of EML4-ALK fusion proteins and mutant EGFR proteins. This finding led to the completion of the present invention. The compound of the present invention can be used as a pharmaceutical composition for preventing and/or treating cancer, lung cancer, non-small cell lung cancer, small cell lung cancer, EML4-ALK fusion polynucleotide-positive and/or mutant EGFR polynucleotide-positive cancer, EML4-ALK fusion polynucleotide-positive and/or mutant EGFR polynucleotide-positive lung cancer, or EML4-ALK fusion polynucleotide-positive and/or mutant EGFR polynucleotide-positive non-small cell lung cancer, etc.

  本发明提供了一种可作为 EML4-ALK 融合蛋白和突变 EGFR 蛋白激酶活性抑制剂的化合物。 由于对具有抑制 EML4-ALK 融合蛋白和突变型表皮生长因子受体蛋白的激酶活性的化合物进行了广泛深入的研究，本发明的发明人发现本发明的二（芳基氨基）芳基化合物具有抑制 EML4-ALK 融合蛋白和突变型表皮生长因子受体蛋白的激酶活性的作用。这一发现促成了本发明的完成。本发明的化合物可用作预防和/或治疗癌症、肺癌、非小细胞肺癌、小细胞肺癌、EML4-ALK融合多核苷酸阳性和/或突变型表皮生长因子受体多核苷酸阳性癌症的药物组合物、EML4-ALK 融合多核苷酸阳性和/或突变型表皮生长因子受体多核苷酸阳性肺癌，或 EML4-ALK 融合多核苷酸阳性和/或突变型表皮生长因子受体多核苷酸阳性非小细胞肺癌等。
• DE895151
  申请人：——

  公开号：——

  公开（公告）日：——